At the frontline of an autoimmune attack are rogue immune cells turned foe against the body they were created to protect. Scientists study the complex etiology of autoimmune disorders to restore the broken balance.
The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.
Traditional snakebite antivenom relies on a century-old technology. To find safer and more effective treatments for one of the world’s most neglected tropical diseases, scientists are designing new therapies, ranging from camel nanobodies to human recombinant antibodies and small molecule drugs.
COVID-19 has gotten a little better at infecting cells and dodging antibodies with each set of mutations in new variants. Omicron is the best at dodging antibodies, but its modified structure sacrificed virulence for antibody resistance.
Recurrent high fevers in children are always worrying, but by studying patient cells, immunologist Lori Broderick hopes to reveal the underlying causes of these disorders.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.